RNA
Atrium Therapeutics, Inc.
7.90$
-0.8%
vs. previous close
Closing price · As of: Oct 7, 2026
Statements
Income Statement
All figures per share in USD.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 0.04 | 0.03 | 0.04 | 0.02 | 0.02 | 0.02 | 0.01 | 0.03 | 0.09 | 0.05 | 1.15 | 0.18 | 2.10 | |
| 0.64 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | – | 1.07 | – | 0.09 | 0.01 | 0.02 | – | |
| -0.61 | 0.02 | 0.03 | 0.01 | 0.02 | 0.02 | 0.01 | -1.04 | 0.09 | 0.05 | 1.14 | 0.16 | 2.07 | |
| 0.64 | 0.69 | 0.77 | 0.60 | 0.63 | 0.74 | 0.77 | 1.07 | 1.12 | 1.08 | 0.97 | 0.90 | 12.01 | |
| 0.19 | 0.21 | 0.16 | 0.19 | 0.19 | 0.22 | 0.26 | 0.28 | 0.04 | 1.78 | 1.18 | 0.60 | 3.90 | |
| 0.19 | 0.90 | 0.92 | 0.79 | 0.81 | 0.96 | 1.03 | 0.28 | 0.06 | 2.86 | 2.15 | 1.48 | 6.98 | |
| -0.79 | -0.88 | -0.89 | -0.77 | -0.80 | -0.94 | -1.02 | -1.32 | -0.06 | -2.81 | -1.01 | -1.32 | -5.64 | |
| – | 0.01 | – | – | – | – | – | – | – | – | – | – | – | |
| -0.71 | -0.79 | -0.79 | -0.66 | -0.65 | -0.80 | -0.90 | -1.21 | -0.06 | -2.81 | -0.97 | -1.18 | -5.46 | |
| -0.08 | 0.00 | 0.01 | – | – | – | – | – | 0.00 | 0.00 | – | – | – | |
| -0.71 | -0.79 | -0.79 | -0.66 | -0.65 | -0.80 | -0.90 | -1.21 | -0.06 | -2.81 | -0.97 | -1.18 | -5.45 | |
| -0.78 | -0.87 | -0.88 | -0.77 | -0.79 | -0.94 | -1.01 | -1.31 | -0.06 | -2.80 | -0.96 | -1.30 | -5.56 |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 7, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.